Philip J. Young Chairman and CEO
Baxter Phillips III COO & Director

Baxter is a seasoned life sciences executive whose experience spans the continuum from preclinical drug research and manufacturing to product launch, commercialization and operations management and finance.
In his 20+ years in the pharmaceulical industry he has served as a director and C-Level executive and director of multiple public and private companies, including insmed (INSM), Asertio (ASRT), and Neurogastrx. He has a B.S. in Biology from Hampden-Sydney College and an MBA from The Mason School of Business at the College of William and Mary.

Mathew Lee Chief Financial Officer

Mathew has over 15 years of experience as a finance executive currently serving as president of Manning Lee Management Ltd., providing CFO services to publicly traded companies. Mathew specializes in providing M&A accounting, management, securities regulatory compliance, and corporate secretarial services. Mathew is a CPA Charterholder and earned a B. Comm from the University of British Columbia.

Maghsoud Dariani Chief Science Officer
Michael Petter Director

Michael is an accomplished leader and entrepreneur in the psychedelics and cannabis industry, co-founding and acting as a director of several companies that successfully completed M&A transactions. He holds a Bachelors in Computer Science from London University and is a chartered engineer and private pilot. Since January 2009, he has been the Managing Director of Eyvo eProcurement Solutions, a US-based private company that is a leading eProcurement provider in the SaaS space. Mike was co-founder and director of Eleusian Biosciences Corp., which the company acquired in July 2020.

Frederick D Sancilio, Ms, PhD Regulatory, CMC, Clinical Development

Dr. Sancilio is a serial entrepreneur in the healthcare feld and is currenty a prnciple of Cleanway Global, Inc., a pharmaceutical development advisory service. He has served as an executive and director of both private and public companies, including Applied Analytical Industries Inc., aaiPharma, Inc., Endeavor Pharmaceutical Company, Aesgen, Inc., Sancilio & Company, Alpha Cognition, Inc., TrippBio, Inc., Omega Blu, LLC, and Nation’s Bank of North Carolina. He was appointed as a Research Professor at Florida Atlantic University and was an adjunct professor of chemistry at the University of North Carolina. Dr. Sancilo received his Master of Science and Doctorate degrees from Rutgers, The State University of New Jersey.